Shareholder alert: pomerantz law firm investigates claims on behalf of revance therapeutics, inc. - rvnc

New york, ny / accesswire / november 8, 2024 / pomerantz llp is investigating claims on behalf of investors of revance therapeutics, inc. ("revance" or the "company") (nasdaq:rvnc). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
RVNC Ratings Summary
RVNC Quant Ranking